Zobrazeno 1 - 6
of 6
pro vyhledávání: ''
Autor:
Min Ji Jeon, Young Kee Shong, Meihua Jin, Jonghwa Ahn, Tae Yong Kim, Dong Eun Song, Sang-Yeob Kim, Yeon-Mi Ryu, Won Bae Kim, Eyun Song, Won Gu Kim
Publikováno v:
Thyroid. 31:61-67
Background: Advanced thyroid cancers, including differentiated thyroid carcinoma (DTC) with distant metastasis, and anaplastic thyroid carcinoma (ATC), are associated with poor clinical outcomes an...
Autor:
Lauren B. Smith, Mark S. Kaminski, Anca M. Avram, Scott J. Wilderman, Yuni K. Dewaraja, Peter L. Roberson, Meredith A. Morgan, Matthew J. Schipper
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 32:309-319
Non-Hodgkin Lymphoma patients respond differently to therapy according to inherent biological variations. Pretherapy biomarkers may improve dose-response prediction.Hybrid single-photon emission computed tomography (SPECT)/computed tomography (CT) th
Autor:
Gabriele Pöpperl, Thomas Helmberger, Rupert Schmid, Klaus Tatsch, Tobias Franz Jacobs, Wolfgang Münzing
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 20:200-208
Transarterial embolization of branches of the hepatic artery with biocompatible 90Y-labeled microspheres (SIR-Spheres) is a local treatment modality for patients with liver tumors, which, most recently, has become available in Europe. The aim of this
Publikováno v:
Journal of Medicinal Food. 6:371-377
Maitake D-Fraction, extracted from maitake mushroom, has been reported to exert its antitumor effect in tumor-bearing mice by enhancing the immune system through activation of macrophages, T cells, and natural killer (NK) cells. In a previous study,
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 15:381-386
Neuron-specific enolase (NSE) and lactate dehydrogenase (LDH) are tumor markers of small cell lung cancer (SCLC) which were reported to predict outcome of patients with SCLC. We previously reported that dipyridamole-modulated Tc-99m sestamibi (dipyri
Autor:
Robert T. Maguire, Jack Gerstbrein, Sara J. Miller, James D. Austin, Richard D. Williams, Daniel Kahn
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 14:99-111
There is currently no curative therapy for men who have disseminated prostate cancer following failed radical prostatectomy. The purpose of this trial was to investigate systemic radioimmunotherapy in these men. Eight patients with occult metastatic